[Thiazides--a first choice against high blood pressure].
Thiazide therapy of hypertension has increased substantially in Norway during the last decade. This is caused partly by changed dosage recommendations - which has led to fewer side effects - and an increased awareness of the cost associated with hypertension therapy. Thiazide therapy is among one of the most cost-effective drug therapies within preventive cardiology. Prevention of primary endpoints such as cerebrovascular disease, cardiovascular mortality and congestive heart failure is well documented.